Abstract:Background: Despite growing interest in the clinical translation of polygenic risk scores (PRSs), it remains uncertain to what extent genomic information can enhance the prediction of psychiatric outcomes beyond the data collected during clinical visits alone. Objective: This study aimed to assess the clinical utility of incorporating PRSs into a suicide risk prediction model trained on electronic health records (EHRs) and patient-reported surveys among patients admitted to the emergency department. Methods: Study participants were recruited from the psychiatric emergency department at Massachusetts General Hospital. There were 333 adult patients of European ancestry who had high-quality genotype data available through their participation in the Mass General Brigham Biobank. Multiple neuropsychiatric PRSs were added to a previously validated suicide prediction model in a prospective cohort enrolled between February 4, 2015, and March 13, 2017. Data analysis was performed from July 11, 2022, to August 31, 2023. Suicide attempt was defined using diagnostic codes from longitudinal EHRs combined with 6-month follow-up surveys. The clinical risk score for suicide attempt was calculated from an ensemble model trained using an EHR-based suicide risk score and a brief survey, and it was subsequently used to define the baseline model. We generated PRSs for depression, bipolar disorder, schizophrenia, suicide attempt, and externalizing traits using a Bayesian polygenic scoring method for European ancestry participants. Model performance was evaluated using area under the receiver operator curve (AUC), area under the precision-recall curve, and positive predictive values. Results: Of the 333 patients (n=178, 53.5% male; mean age 36.8, SD 13.6 years; n=333, 100% non-Hispanic and n=324, 97.3% self-reported White), 28 (8.4%) had a suicide attempt within 6 months. Adding either the schizophrenia PRS or all PRSs to the baseline model resulted in the numerically highest discrimination (AUC 0.86, 95% CI 0.73-0.99) compared to the baseline model (AUC 0.84, 95% Cl 0.70-0.98). However, the improvement in model performance was not statistically significant. Conclusions: In this study, incorporating genomic information into clinical prediction models for suicide attempt did not improve patient risk stratification. Larger studies that include more diverse participants are required to validate whether the inclusion of psychiatric PRSs in clinical prediction models can enhance the stratification of patients at risk of suicide attempts.

Relationship of Major Depressive Disorder and Schizophrenia Polygenic Risk Scores to Suicide: A Comparison Between European and Asian Ancestry Populations

Suicide Risk in Major Affective Disorder: Results from a National Survey in China.

Comparative Genetic Architectures of Schizophrenia in East Asian and European Populations

Enhancing Suicide Risk Prediction With Polygenic Scores in Psychiatric Emergency Settings: Prospective Study

Characteristics and Risk Factors for Suicide in People with Schizophrenia in Comparison to Those Without Schizophrenia

GWAS of Suicide Attempt in Psychiatric Disorders and Association with Major Depression Polygenic Risk Scores.

Asian-European Differentiation of Schizophrenia-Associated Genes Driven by Admixture and Natural Selection

Genome-wide association study meta-analysis of suicide death and suicidal behavior

Genome-wide association study of suicidal behaviour severity in mood disorders

Genetic Polymorphisms in the Scn8a Gene Are Associated with Suicidal Behavior in Psychiatric Disorders in the Chinese Population

Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries

Polygenic risk scores for precision psychiatry: a study on the effect heterogeneity of antidepressants

The Association Between Family History and Genomic Burden with Schizophrenia Mortality: a Swedish Population-Based Register and Genetic Sample Study

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study

Characteristics of Schizophrenia Suicides Compared with Suicides by Other Diagnosed Psychiatric Disorders and Those Without a Psychiatric Disorder

Association between polygenic risk scores combined with clinical characteristics and antidepressant efficacy

Analysis of genetic differences between psychiatric disorders: Exploring pathways and cell-types/tissues involved and ability to differentiate the disorders by polygenic scores

Risk Factors, Clinical Features, and Polygenic Risk Scores in Schizophrenia and Schizoaffective Disorder Depressive-Type

Incidence Rate of Suicidal Behavior Stratified by Diagnosis Among High-Risk Patients

Analyzing a single nucleotide polymorphism in schizophrenia: a meta-analysis approach

Genetics of suicide ideation. A role for inflammation and neuroplasticity?